Tumefactive demyelinating disease treated with decompressive craniectomy.

Petra Nilsson, Elna-Marie Larsson, Babar Kahlon, Carl-Henrik Nordström, Bo Norrving

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Tumefactive demyelinating disease (TDD) is a rare primary demyelinating disease with diagnostic and therapeutic challenges. Methods and results: We report a 50-year old woman with TDD successfully treated with decompressive craniectomy and corticosteroids. The patient presented with seizures, subacute progressive hemispheric syndrome, and a tumourlike abnormality on MRI. Demyelinating disease was initially considered unlikely. Due to a rapidly evolving herniation syndrome hemicraniectomy was performed. Outcome was favourable with only very mild neurological deficits 6 weeks later. Conclusion: TDD should be considered as a differential diagnosis in tumour-like presentations, and appears to have distinctive neuroimaging features. In the advent of treatement failure from high dose corticosteroids and plasmapheresis and development of severe mass effect, decompressive hemicraniectomy is an important treatment option.
Original languageEnglish
Pages (from-to)639-642
JournalEuropean Journal of Neurology
Volume16
DOIs
Publication statusPublished - 2009

Subject classification (UKÄ)

  • Neurology

Fingerprint

Dive into the research topics of 'Tumefactive demyelinating disease treated with decompressive craniectomy.'. Together they form a unique fingerprint.

Cite this